[1]
T. Diyora and A. Ranajn, “Sacubitril/Valsartan and elevated prothrombin time/international normalized ratio in the absence of anticoagulant therapy: a newly recognized potential adverse drug reaction”, EJCRIM, vol. 13, no. 6, Jun. 2026, doi: 10.12890/2026_006801.